Publications:

---

Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia.

Annals Of Hematology

Chiriches, Claudia C; Khan, Dilawar D; Wieske, Maria M; Guillen, Nathalie N; Rokicki, Michal M; Guy, Carol C; Wilson, Marieangela M; Heesom, Kate J KJ; Ottmann, Oliver Gerhard OG; Ruthardt, Martin M

Publication Date: 2022-10

Variant appearance in text: PI3K: N822K

PubMed Link: 35941390

Variant Present in the following documents:

• Main text
• 277_2022_Article_4905.pdf

View BVdb publication page

---

Gastrointestinal Stromal Tumors Mimicking Gynecologic Disease: Clinicopathological Analysis of 20 Cases.

Diagnostics (Basel, Switzerland)

Liu, Ying Y; Shahi, Maryam M; Miller, Karin K; Meyer, Christian F CF; Hung, Chien-Fu CF; Wu, T-C TC; Vang, Russell R; Xing, Deyin D

Publication Date: 2022-06-27

Variant appearance in text: PIK3CA: N822K

PubMed Link: 35885469

Variant Present in the following documents:

• Main text
• diagnostics-12-01563.pdf

View BVdb publication page

---

PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors.

Oncotarget

Smith, Amanda M AM; Zhang, Christine R C CRC; Cristino, Alexandre S AS; Grady, John P JP; Fink, J Lynn JL; Moore, Andrew S AS

Publication Date: 2019-10-08

Variant appearance in text: PI3K: N822K

PubMed Link: 31645898

Variant Present in the following documents:

• oncotarget-10-5755.pdf

View BVdb publication page

---

Integrated Molecular Characterization of Testicular Germ Cell Tumors.

Cell Reports

Shen, Hui H; Shih, Juliann J; Hollern, Daniel P DP; Wang, Linghua L; Bowlby, Reanne R; Tickoo, Satish K SK; Thorsson, Vésteinn V; Mungall, Andrew J AJ; Newton, Yulia Y; Hegde, Apurva M AM; Armenia, Joshua J; Sánchez-Vega, Francisco F; Pluta, John J; Pyle, Louise C LC; Mehra, Rohit R; Reuter, Victor E VE; Godoy, Guilherme G; Jones, Jeffrey J; Shelley, Carl S CS; Feldman, Darren R DR; Vidal, Daniel O DO; Lessel, Davor D; Kulis, Tomislav T; Cárcano, Flavio M FM; Leraas, Kristen M KM; Lichtenberg, Tara M TM; Brooks, Denise D; Cherniack, Andrew D AD; Cho, Juok J; Heiman, David I DI; Kasaian, Katayoon K; Liu, Minwei M; Noble, Michael S MS; Xi, Liu L; Zhang, Hailei H; Zhou, Wanding W; ZenKlusen, Jean C JC; Hutter, Carolyn M CM; Felau, Ina I; Zhang, Jiashan J; Schultz, Nikolaus N; Getz, Gad G; Meyerson, Matthew M; Stuart, Joshua M JM; , ; Akbani, Rehan R; Wheeler, David A DA; Laird, Peter W PW; Nathanson, Katherine L KL; Cortessis, Victoria K VK; Hoadley, Katherine A KA

Publication Date: 2018-06-12

Variant appearance in text: PIK3CA: N822K

PubMed Link: 29898407

Variant Present in the following documents:

• NIHMS977848-supplement-2.xlsx, sheet 1

View BVdb publication page

---

The AURORA pilot study for molecular screening of patients with advanced breast cancer-a study of the breast international group.

Npj Breast Cancer

Maetens, Marion M; Brown, David D; Irrthum, Alexandre A; Aftimos, Philippe P; Viale, Giuseppe G; Loibl, Sibylle S; Laes, Jean-François JF; Campbell, Peter J PJ; Thompson, Alastair A; Cortes, Javier J; Seiler, Sabine S; Vinnicombe, Sara S; Oliveira, Mafalda M; Rothé, Françoise F; Bareche, Yacine Y; Fumagalli, Debora D; Zardavas, Dimitrios D; Desmedt, Christine C; Piccart, Martine M; Loi, Sherene S; Sotiriou, Christos C

Publication Date: 2017

Variant appearance in text: PIK3CA: N822K

PubMed Link: 28685159

Variant Present in the following documents:

• 41523_2017_26_MOESM12_ESM.xlsx, sheet 1

View BVdb publication page

---

Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitors.

Leukemia

Wichmann, C C; Quagliano-Lo Coco, I I; Yildiz, Ö Ö; Chen-Wichmann, L L; Weber, H H; Syzonenko, T T; Döring, C C; Brendel, C C; Ponnusamy, K K; Kinner, A A; Brandts, C C; Henschler, R R; Grez, M M

Publication Date: 2015-02

Variant appearance in text: PI3K: N822K

PubMed Link: 24897507

Variant Present in the following documents:

• Main text
• leu2014179a.pdf

View BVdb publication page

---

Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia.

Blood

Matsuura, Shinobu S; Yan, Ming M; Lo, Miao-Chia MC; Ahn, Eun-Young EY; Weng, Stephanie S; Dangoor, David D; Matin, Mahan M; Higashi, Tsunehito T; Feng, Gen-Sheng GS; Zhang, Dong-Er DE

Publication Date: 2012-03-29

Variant appearance in text: PI3K: N822K

PubMed Link: 22223820

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Profiling critical cancer gene mutations in clinical tumor samples.

Plos One

MacConaill, Laura E LE; Campbell, Catarina D CD; Kehoe, Sarah M SM; Bass, Adam J AJ; Hatton, Charles C; Niu, Lili L; Davis, Matt M; Yao, Keluo K; Hanna, Megan M; Mondal, Chandrani C; Luongo, Lauren L; Emery, Caroline M CM; Baker, Alissa C AC; Philips, Juliet J; Goff, Deborah J DJ; Fiorentino, Michelangelo M; Rubin, Mark A MA; Polyak, Kornelia K; Chan, Jennifer J; Wang, Yuexiang Y; Fletcher, Jonathan A JA; Santagata, Sandro S; Corso, Gianni G; Roviello, Franco F; Shivdasani, Ramesh R; Kieran, Mark W MW; Ligon, Keith L KL; Stiles, Charles D CD; Hahn, William C WC; Meyerson, Matthew L ML; Garraway, Levi A LA

Publication Date: 2009-11-18

Variant appearance in text: PIK3CA: N822K

PubMed Link: 19924296

Variant Present in the following documents:

• pone.0007887.pdf

View BVdb publication page

---

The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors.

Experimental Hematology

Lin, Tzu-Yin TY; Bear, Misty M; Du, Zhenjian Z; Foley, Kevin P KP; Ying, Weiwen W; Barsoum, James J; London, Cheryl C

Publication Date: 2008-10

Variant appearance in text: PI3K: Asn822Lys

PubMed Link: 18657349

Variant Present in the following documents:

• Main text

View BVdb publication page

---